ALMS
ALUMIS INC. · Healthcare · Market cap $1.4B
Insiders sold $534K net in the last 90 days ·6 sellers, 0 buyers· latest Form 4 filed Aug 5, 2026
Insider Buying
$51.0M
reported purchases (SEC code P)
Insider Selling
$534K
reported sales (SEC code S)
Unique Insiders
10
in the rolling window
Latest filing
Aug 5, 2026
Drappa Jorn
ALUMIS INC. (ALMS) has 32 SEC Form 4 filings (63 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Aug 5, 2026.
Inside the rolling window, 10 insiders at ALUMIS INC. reported 28 open-market purchases totaling $51.0M and 7 open-market sales totaling $534K. The most active filer is Director AKKARAJU SRINIVAS with 13 filings. Insiders have net sold $534K over the trailing 6 months. The most recent open-market filing is a sale of 2,447 shares by Chief Medical Officer Drappa Jorn, dated Aug 3, 2026, worth $65K.
- Industry:Biotechnology
- CEO:Martin Babler
- Employees:223
- HQ:South San Francisco, CA, US
- IPO:2024-06-28
| Source | |||||||
|---|---|---|---|---|---|---|---|
Drappa JornFirst filing | Chief Medical Officer | Sale | 2,447 | $65K | Aug 5 | -59.1% | SEC ↗ |
Goldstein David MFirst filing | Chief Scientific Officer | Sale | 2,596 | $68K | Aug 5 | -59.1% | SEC ↗ |
| Chief Legal Officer | Sale | 1,364 | $36K | Aug 5 | -59.1% | SEC ↗ | |
Bradley Mark ChristopherFirst filing | Chief Development Officer | Sale | 2,572 | $68K | Aug 5 | -59.1% | SEC ↗ |
Schroer John R.First filing | Chief Financial Officer | Sale | 3,282 | $87K | Aug 5 | -59.1% | SEC ↗ |
Hardiman Roy C.First filing | Chief Business & Strategy Ofcr | Sale | 2,692 | $71K | Aug 5 | -59.1% | SEC ↗ |
Pangali SanamFirst filing | Chief Legal Officer | Sale | 5,000 | $140K | Jul 8 | -62.7% | SEC ↗ |
| Director | Purchase | 588,235 | $10.0M | Jan 13 | -49.8% | SEC ↗ | |
| Director, 10% Owner | Purchase | 411,764 | $7.0M | Jan 12 | -47.4% | SEC ↗ | |
| 10% Owner | Purchase | 411,764 | $7.0M | Jan 12 | — | SEC ↗ | |
| 10% Owner | Purchase | 411,764 | $7.0M | Jan 12 | — | SEC ↗ | |
| Director | Purchase | 186,377 | $1.8M | Dec 9 | — | SEC ↗ | |
| Director | Purchase | 96,000 | $725K | Dec 4 | — | SEC ↗ | |
| Director | Purchase | 100,000 | $775K | Dec 4 | — | SEC ↗ | |
| Director | Purchase | 66,027 | $540K | Dec 4 | — | SEC ↗ | |
| Director | Purchase | 48,537 | $371K | Dec 1 | — | SEC ↗ | |
| Director | Purchase | 38,702 | $296K | Dec 1 | — | SEC ↗ | |
| Director | Purchase | 86,350 | $644K | Dec 1 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 72,212 | $533K | Nov 25 | — | SEC ↗ | |
| 10% Owner | Purchase | 72,212 | $533K | Nov 25 | — | SEC ↗ | |
| 10% Owner | Purchase | 72,212 | $533K | Nov 25 | — | SEC ↗ | |
| Director | Purchase | 125,743 | $905K | Nov 24 | — | SEC ↗ | |
| Director | Purchase | 914 | $5K | Nov 19 | — | SEC ↗ | |
| Director | Purchase | 102,652 | $621K | Nov 19 | — | SEC ↗ | |
| Director | Purchase | 137,772 | $904K | Nov 19 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does ALMS have?
ALUMIS INC. (ALMS) has 32 SEC Form 4 filings (63 transaction rows) in the rolling 365-day window, disclosed by 10 distinct insiders. Most recent filing: Aug 5, 2026.
When was the most recent SEC Form 4 filing for ALMS?
The most recent Form 4 filing for ALMS on Tracefour is dated Aug 5, 2026.
Who is the most active insider at ALMS?
The most active SEC Form 4 filer at ALMS in the rolling window is Director AKKARAJU SRINIVAS, with 13 filings.
What is the net insider flow at ALMS over the last 6 months?
Over the trailing 180 days, insiders at ALMS have net sold $534K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ALMS in the current window?
Inside the rolling window, insiders at ALMS bought $51.0M and sold $534K based on SEC Form 4 filings.
Can I get alerts for ALMS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ALUMIS INC. (ALMS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
ALUMIS INC. is in the Healthcare sector.